PURPOSE. Malignant melanomas of the ocular surface (conjunctival melanoma [CM]) and within the eye (uveal melanoma [UM]) show different types of metastatic behavior. While CM has a propensity to spread first to regional lymph nodes, UM metastasizes almost exclusively via the hematogenic route to the liver. We investigated whether these different metastatic patterns might be attributable to differential hem-and lymphangiogenic characteristics of CM and UM cells.
M alignant melanomas of the ocular surface (conjunctival melanoma [CM] ) and within the eye (uveal melanoma [UM] ) show a different metastatic behavior. Conjunctival melanoma has a propensity to first spread into regional lymph nodes. [1] [2] [3] On the other hand, UM spreads almost exclusively via the hematogenic pathway with a strong hepatic tropism, [4] [5] [6] and lymphatic metastases have been described sporadically in advanced cases with extrascleral tumor extension. 7, 8 The induction of angiogenesis with sprouting of new capillary blood vessels from preexisting ones generally is considered as one of the six hallmarks of cancer. 9 Hemangiogenesis is not only mandatory for primary tumor growth once it exceeds the size sustainable by mere nutrient and oxygen diffusion (approximately 2-to 3-mm tumor diameter), 10, 11 but it also is regarded as the initial preparatory step for developing distant metastases. 12 Tumor-associated lymphangiogenesis (i.e., outgrowth of new from preexisting lymphatic vessels) is identified as the initial step in lymphogenic metastasis of several tumors. [13] [14] [15] Key mediators of hem-and lymphangiogenesis are, among other factors, members of the VEGF family, released from the tumor cells as well as the tumor microenvironment. [16] [17] [18] [19] Vascular endothelial growth factor-A has a central role in hemangiogenesis, whereas lymphangiogenesis is driven mainly by VEGF-C and -D. [16] [17] [18] [19] [20] In eyes with UM, elevated VEGF-A levels have been detected and associated with larger tumor dimensions, raised distant metastasis rates, and poor survival rates. [21] [22] [23] Although VEGF-C and -D also are expressed by UM cells, 24, 25 intraocular melanomas without extraocular extension do not show any lymphatic formations within the eye. 26 The human eye-apart from the extraocular conjunctiva and limbus-is physiologically devoid of lymphatic vessels. [27] [28] [29] [30] [31] When extraocular tumor extension provides routes of entry through the sclera, lymphatics may grow into the inner eye, and their presence is correlated with a poorer survival. 26, 32, 33 In CMs, primary malignancies of the conjunctiva, tumor-associated lymphangiogenesis has been shown to be a significant prognostic predictor for an increased risk of local recurrence, lymphatic spread, distant metastasis, and melanoma-related death. 34 However, molecular data of VEGF-A, -C, and -D expressions are totally lacking for CM.
The purpose of the present study was to analyze whether a different hem-and lymphangiogenic capacity of CM and UM cells contributes to the different metastatic behaviors of conjunctival and uveal melanomas. Therefore, we studied VEGF-A, -C, and -D expression in human CM and UM cell lines as well as the impact of these cell lines on blood (BEC) and lymphatic (LEC) endothelial cell proliferation and migration.
METHODS

Cell Lines and Culturing Conditions
Human CM cell lines (CM2005.1, CRMM1, and CRMM2) and UM cell lines (Mel270, Mel290, and OM431) were used for the experiments. Cell line CM2005.1 was isolated by de Keizer et al., 35 CRMM1 and CRMM2 were isolated by Nareyeck et al.,
36
Mel270 and Mel290 were isolated by Chen et al. 37 and Verbik et al., 38 and OM431 was isolated by Albert et al. 39 All CM cell lines used for the present work were kindly provided by one of the authors (MJJ), and all UM cell lines were kindly provided by Bruce R. Ksander (Schepens Eye Research Institute, Boston, MA, USA). Cell line CM2005.1 derived from a primary tumor originally located at the palpebral conjunctiva of the upper eyelid, and was isolated from a local recurrence appearing 3 years after initial tumor removal. 35 The tumor displayed a spindle-cell type, 40 and immunohistochemical staining was positive for melanocytic markers S-100, MelanA, and HMB 45. 35 Cell line CRMM1 derived from a tumor originally located in the bulbar conjunctiva and was isolated from a local recurrence. 36 Cell line CRMM1 showed a high expression of tumor marker HMB-45 and displayed spindle-cell morphology. 40 Also, CRMM2 cells derived from a tumor originally located at the bulbar conjunctiva and was isolated from a recurrent tumor 36 showing high HMB-45 expression and displaying a spindle-cell type. 40 All tested CM cell lines were shown to have either BRAF (CRMM1, CM2005.1) or NRAS (CRMM2) mutations. 40 Uveal melanoma cell line Mel270 derived from a ciliary body melanoma, which received neoadjuvant brachytherapy (I 125 plaque) before enucleation. Hepatic metastases occurred 3 years after removal of the primary tumor. 37 Cell line Mel290 was isolated from a primary uveal melanoma. 38, 41 Cell lines Mel270 and Mel290 showed no BRAF, NRAS, KRAS, or HRAS mutations of the genomic DNA. 41, 42 A GNAQ mutation was detected in Mel270, but not in Mel290. 43, 44 Cell line Mel270 is composed primarily of spindle cells, while Mel290 shows epithelioid cell morphology. 45 Cell line OM431 was isolated from a recurrent epithelioid cell type choroidal melanoma. 39, 46 Genetically, OM431 revealed a BRAF mutation and a GNAQ and GNA11 wild-type. 47 Tumor cell lines were cultured in melanoma medium, composed of Roswell Park Memorial Institute (RPMI) 1640 medium (Life Technologies, Darmstadt, Germany) with 1% pen-strep/L-glutamine, 1% sodium pyruvate, 0.4% 2-b-mercaptoethanol (PAA Laboratories, Pasching, Austria) and 10% fetal bovine serum (FBS; Life Technologies). To generate tumor cellconditioned medium, melanoma medium containing only 1% FBS (Life Technologies) was used. Blood endothelial cells and lymphatic endothelial cells (Promocell, Heidelberg, Germany) were cultured in Endothelial Cell Growth Medium MV2 Kit with all supplied supplements (Promocell), which contained additionally 1% pen-strep/L-glutamine (PAA Laboratories). For proliferation assays, minimal endothelial medium was used, supplemented only with 1% fetal calf serum (FCS; Promocell). Cell lines were cultured with 20% O 2 , 5% CO 2 , and 378C, and were passaged when 80% to 90% confluent. Cell lines were subcultured with Trypsin/EDTA (0.04%, 0.03%) and Trypsin Neutralizing Solution (TNS; 0.05% Trypsin Inhibitor in 0.1% BSA; Promocell).
Tumor Cell-Conditioned Medium
Tumor cell lines were seeded at a density of 1 3 10 5 cells/mL in melanoma medium. After 24 hours the medium was changed to minimal melanoma medium and the cell lines were incubated with 1% O 2 , 5% CO 2 at 378C in a CO 2 -Incubator with O 2 control (CO 2 -Incubator CB 150; Binder, Tuttlingen, Germany). Culture supernatant was collected after 24 hours, centrifuged for 10 minutes at 500g, and stored at À208C until use. Stagnant (incubated under 378C and hypoxic conditions), but unconditioned melanoma medium without supplements was used as control. Equal parts of tumor cell culture supernatant and minimal endothelial cell medium were mixed to create tumor cell-conditioned medium to be used in LEC/ BEC proliferation and migration assays. The collection of supernatants was carried out for each melanoma cell line three times using different cell passages.
mRNA Expression
Cell lines were cultivated while producing conditioned medium. The mRNA of melanoma cell lines was isolated after 24 hours of culture in minimal melanoma medium and the synthesis of complementary DNA (cDNA) was performed as published previously. 48 Then, 25 ng cDNA, 0.4 lM corresponding forward and reverse primer, and SsoFast EvaGreen Supermix (Bio-Rad, Hercules, CA, USA) were used per reaction for RT-PCR analyses. The primers were designed as published previously. 39 Primer sequences of the respective genes are shown in the Table. The RT-PCR was performed as follows: an initial denaturation step of 958C for 2 minutes, then 40 cycles at 958C for 5 seconds, and at 568C for 15 seconds, followed by an additional denaturation step for 60 seconds at 958C. All PCR reactions were performed as duplicate and a nontemplate control (NTC) was included in all experiments. After PCR amplification, PCR products were separated by electrophoresis for 100 minutes at 150 V on a 2% agarose gel. The agarose gel was stained with GelRed (Biotium, Inc., Hayward, CA, USA) and visualized using a ChemiDoc imager (Bio-Rad). Experiments were repeated three times with different cell line passages.
Protein Expression
Cell lines were plated at a concentration of 2 3 10 5 cells/mL in a 6-well plate with melanoma medium, and kept for 24 hours in 20% O 2 , 5% CO 2 , and 378C. Melanoma medium was replaced by FBS free melanoma medium and cells were incubated again for 24 hours in 1% O 2 , 5% CO 2 , and 378C. Afterwards, supernatants were collected to measure secreted VEGF-A, -C, and -D protein levels using human VEGF-A, -C, and -D Duoset ELISA kits (all R&D Systems, Wiesbaden, Germany). Absorbance was measured at 450 and 570 nm using an ELISA plate reader (Epoch Microplate Spectrophotometer; Biotek, Bad Friedrichshall, Germany). The quantitative analysis was performed using the software of Elisakit.com Pty Ltd. (available in the public domain at http://elisaanalysis.com/, Melbourne, Australia). The assays were performed in triplicate and repeated three times with different cell line passages.
Proliferation Assay
The MTT (3-[4,5-dimethylthiazol-2yl]-2,5-diphenyl-tetrazolium bromide)-based proliferation assays were performed using a TACS MTT Cell Proliferation Assay kit, (Trevigen, 
Migration Assay
Blood or lymphatic endothelial cells were seeded in a marked 96-well plate at a concentration of 3 3 10 4 cells/well in endothelial cell medium overnight. The medium was replaced by endothelial cell medium supplemented with 0.5 mM hydroxyurea (Sigma-Aldrich, Taufkirchen, Germany) to arrest cell growth and incubated for a further 24 hours. 49 This step inhibits proliferation; thus, allowing specific testing of migration. A scratch was made using a sterile 100-lL pipette tip. In each well, a uniform straight line was drawn with the pipette tip through the confluent endothelial cell monolayer from the 6 o'clock toward the 12 o'clock position, which resulted in a uniform reproducible distance between the wound edges of the cell-free scratch. Cells were washed twice with PBS, and equal volumes of tumor cell-conditioned medium and minimal endothelial cell medium were added. At time points 0 and 24 hours, the migration was photographically documented. 
RESULTS
Expression of VEGF-A, -C, and -D mRNA and Protein in CM and UM Cell Lines
We performed RT-PCR to analyze the mRNA expression of VEGF-A, -C, and -D by CM cell lines CM2005.1, CRMM1, and CRMM2, and by UM cell lines Mel270, Mel290, and OM431. All investigated cell lines expressed VEGF-A mRNA (Fig.  1A) . We also analyzed VEGF-A protein levels using a specific ELISA. The supernatants of all investigated CM and UM cell lines expressed VEGF-A protein (Fig. 1B) . Cell line OM431 expressed the highest VEGF-A protein level, and Mel290 the lowest. Comparing the three CM with the three UM cell lines, the VEGF-A protein expression approached no significance (P ¼ 0.64).
All tested CM and UM cell lines expressed VEGF-C mRNA (Fig. 1C) . Interestingly, VEGF-C protein was observed only in the supernatant of the UM cell lines (P ¼ 0.10; Fig. 1D ).
The VEGF-D mRNA and VEGF-D protein were expressed in all six cell lines (Figs. 1E, 1F) , and CM and UM cell lines did not differ significantly for protein expression (P ¼ 0.42).
Impact of CM and UM Cell Lines on BEC and LEC Proliferation
Blood and lymphatic endothelial cells were cultured with CMand UM-conditioned medium, and proliferation was measured after 24 hours (Fig. 2) . All investigated cell lines showed similar proliferative effects on BECs ( Fig. 2A) and LECs (Fig. 2B) . No significant differences between CM and UM cell lines were detectable for BECs (P ¼ 0.86) or LECs (P ¼ 0.90).
Impact of CM and UM Cell Lines on BEC and LEC Migration
Blood and lymphatic endothelial cells were cultured with CMand UM-conditioned medium, and migration was analyzed after 24 hours. Conditioned media of all CM and UM cell lines affected BEC and LEC migration to a similar extent (Fig. 3) . No significant differences between CM and UM cell lines could be observed for BECs (P ¼ 0.56; Fig. 3A) or LECs (P ¼ 0.90; Fig.  3B ).
DISCUSSION
Since CM spreads primarily via the lymphogenic path and UM metastasizes almost exclusively via the hematogenic path, we wanted to know whether these different metastatic patterns might be attributable to differences in the hem-and lymphangiogenic potentials of CM and UM cells. The present study shows that all CM and UM cell lines express VEGF-A, -C, and -D at the mRNA level, and VEGF-A and -D at the protein level. Protein VEGF-C is only produced by UM cell lines. The conditioned medium of CM and UM cell lines has a similar impact on proliferation and migration of BEC and LEC.
Regarding the expression of prohem-and prolymphangiogenic VEGF-A, -C, and -D, we confirmed previous studies for UM. 21, 24, 25, [41] [42] [43] Furthermore, we analyzed-to our knowledge for the first time-the hem-and lymphangiogenic profile of CM cell lines. The CM cell lines expressed VEGF-A and -D at mRNA and protein level, and VEGF-C only at mRNA level. 
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In addition, our proliferation and migration assays neither showed a higher prolymphangiogenic potential of CM cell lines nor a higher prohemangiogenic potential of UM cell lines, suggesting that the type of metastatic behavior does not depend on specific expression profiles of the tumor cells.
Therefore, other factors must have a role in the different routes of metastases formation, and in particular the anatomy of ocular lymphatics may have an important role. While the extraocular conjunctiva and limbus are well-endowed with lymphatic vessels, the inner eye is physiologically devoid of these vessels. [27] [28] [29] [30] [31] The sclera seems to be a natural barrier against invasion of preexisting lymphatic vessels into the eye, despite a high intraocular expression level of VEGF-C, -D, and VEGFR-3 in UMs without extraocular extension. 25, 26, 30 Due to this inaccessibility of the extraocular lymph vessel system, UMs are not able to spread via the lymphogenic route, in contrast to CMs. Only when they have grown outside the eye, may they find their way into the lymph system. 7, 8, 26, 32, 33 Moreover, tumor-associated hem-and lymphangiogenesis is regulated and promoted not only by tumor cells themselves, but also by cells of the tumor microenvironment, including cancer-associated fibroblasts, mesenchymal stem cells, dendritic cells, or macrophages. 19 In fact, via recruitment of VEGF-C and VEGF-D secreting macrophages the expression of primarily prohemangiogenic VEGF-A by CM cells also might indirectly account for the lymphogenic metastatic pattern of CM. 20 Furthermore, we did not analyze the tumor-vessel interaction in terms of regulation of adhesion molecules regulating tumor invasion into both vessel types. In addition, the extracellular matrix as well as cytokines and growth factors are involved in the process of (lymph)angiogenesis and metastasis. 19 The cellular and noncellular components influence each other and can be influenced by the tumor cells. 19 In general, the use of established tumor cell lines as in the present in vitro experiments has its shortcomings. Expression profiles, including prohem-and prolymphangiogenic factors, might to some degree have altered over multiple culturing passages in comparison with primary tumor cells freshly isolated from tumor tissue. Even more importantly, in vitro analyses in general, which in the present case only focus on the impact of CM or UM cell lines on BECs or LECs, can never reflect the complex multidirectional interactions within the tumor microenvironment, which among others result in metastatic spread. Therefore, further studies on the pro(lymph)angiogenic cross talk in the tumor microenvironment are needed to better understand the metastatic mechanism of CM and UM and fine-tune novel anti(lymph)angiogenic treatment strategies for these tumors. 50, 51 In conclusion, CM cell lines do not show a higher prolymphangiogenic potential, and UM cell lines do not reveal a higher prohemangiogenic potential. Therefore, other mechanisms within the tumor microenvironment as well as the anatomical accessibility of the extraocular lymph vessels system might account for the distinct lymphangiogenic versus hemangiogenic metastatic behavior of conjunctival versus uveal melanomas.
